Drug Delivery (Jan 2021)

Role of macrophage in nanomedicine-based disease treatment

  • Siwei Song,
  • Hui Xia,
  • Mengfei Guo,
  • Sufei Wang,
  • Shujing Zhang,
  • Pei Ma,
  • Yang Jin

DOI
https://doi.org/10.1080/10717544.2021.1909175
Journal volume & issue
Vol. 28, no. 1
pp. 752 – 766

Abstract

Read online

Macrophages are a major component of the immunoresponse. Diversity and plasticity are two of the hallmarks of macrophages, which allow them to act as proinflammatory, anti-inflammatory, and homeostatic agents. Research has found that cancer and many inflammatory or autoimmune disorders are correlated with activation and tissue infiltration of macrophages. Recent developments in macrophage nanomedicine-based disease treatment are proving to be timely owing to the increasing inadequacy of traditional treatment. Here, we review the role of macrophages in nanomedicine-based disease treatment. First, we present a brief background on macrophages and nanomedicine. Then, we delve into applications of macrophages as a target for disease treatment and delivery systems and summarize the applications of macrophage-derived extracellular vesicles. Finally, we provide an outlook on the clinical utility of macrophages in nanomedicine-based disease treatment.

Keywords